Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Cancer, Papillary × Radiofrequency Ablation × Clear all

Sponsor

Conditions

Liver Neoplasms 5 Carcinoma, Hepatocellular 5 Neoplasm Metastasis 3 Biliary Tract Neoplasms 2 Squamous Intraepithelial Lesions 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Osteosarcoma 1 Lung Neoplasms 1 Hepatitis B, Chronic 1 HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions 1 Esophageal Squamous Cell Neoplasia (ESCN) 1 Esophageal Squamous Cell Carcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Adrenal Gland Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 AZD 6244 2 vandetanib 1 tremelimumab 1 tovorafenib 1 tanespimycin 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 copanlisib 1 cediranib 1 alectinib 1 Vorinostat 1 Vemurafenib 1 Thyroidectomy 1 Thyroid (USP) 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Ferrosoferric Oxide 1 Ethanol 1 Bortezomib 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡